GlycoMimetics, Inc.
(NASDAQ : GLYC)

( )
GLYC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -11.87%310.610.0%$5071.29m
BNTXBioNTech SE -4.91%334.480.0%$1509.60m
NVAXNovavax, Inc. -7.66%192.6578.2%$1000.81m
AMGNAmgen, Inc. 0.97%200.801.4%$596.73m
GILDGilead Sciences, Inc. 0.00%68.931.0%$502.66m
REGNRegeneron Pharmaceuticals, Inc. -0.93%630.592.7%$480.14m
VRTXVertex Pharmaceuticals, Inc. 9.66%205.001.9%$469.49m
LGVNLongeveron Inc. -22.20%20.430.0%$404.67m
ILMNIllumina, Inc. -2.10%357.663.3%$316.55m
SNSSSunesis Pharmaceuticals, Inc. -10.85%4.110.7%$287.30m
BIIBBiogen, Inc. -2.65%229.501.8%$286.58m
OCGNOcugen, Inc. -4.89%6.030.0%$251.60m
INCYIncyte Corp. -4.08%64.962.4%$161.20m
EXASEXACT Sciences Corp. -5.96%80.2818.0%$157.41m
SGENSeagen Inc. -1.09%158.255.8%$147.19m

Company Profile

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.